Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
PRAX-628 by Praxis Precision Medicines for Epilepsy: Likelihood of Approval
PRAX-628 is under clinical development by Praxis Precision Medicines and currently in Phase II for Epilepsy. According to GlobalData, Phase...
Ulixacaltamide hydrochloride by Praxis Precision Medicines for Essential Tremor: Likelihood of Approval
Ulixacaltamide hydrochloride is under clinical development by Praxis Precision Medicines and currently in Phase III for Essential Tremor. According to...
Elsunersen by Praxis Precision Medicines for Epileptic Encephalopathy: Likelihood of Approval
Elsunersen is under clinical development by Praxis Precision Medicines and currently in Phase III for Epileptic Encephalopathy. According to GlobalData,...